Journal
MEDICINAL RESEARCH REVIEWS
Volume 42, Issue 1, Pages 462-512Publisher
WILEY
DOI: 10.1002/med.21851
Keywords
Acanthamoeba; heterocyclic compounds; keratitis; medicinal chemistry
Categories
Funding
- Sunway University
Ask authors/readers for more resources
Acanthamoeba is a genus of free-living amoebae that often causes sight-threatening keratitis and fatal encephalitis. Developing effective treatments for Acanthamoeba infections remains challenging, highlighting the need for new approaches to eliminate such rare but serious infections.
Acanthamoeba is a genus of free-living amoebae, pervasively found in the environment. Most of its pathogenic species are the causative agent of sight-threatening Acanthamoeba keratitis and fatal granulomatous amoebic encephalitis. Despite the advancements in the field of chemotherapy, treating Acanthamoeba infections is still challenging due to incomplete knowledge of the complicated pathophysiology. In case of infection, the treatment regimen for the patients is often ineffective due to delayed diagnosis, poor specificity, and side-effects. Besides the resistance of Acanthamoeba cysts to most of the drugs, the recurrence of infection further complicates the recovery. Thus, it is necessary to develop an effective treatment which can eradicate these rare, but serious infections. Based on various computational and in vitro studies, it has been established that the synthetic scaffolds such as heterocyclic compounds may act as potential drug leads for the development of antiamoebic drugs. In this review, we report different classes of synthetic compounds especially heterocyclic compounds which have shown promising results against Acanthamoeba. Moreover, the antiamoebic activities of synthetic compounds with their possible mode of actions against Acanthamoeba, have been summarized and discussed in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available